Advanced Medical Solutions Group (LON:AMS) Given Buy Rating at Berenberg Bank

Berenberg Bank reiterated their buy rating on shares of Advanced Medical Solutions Group (LON:AMSFree Report) in a research report report published on Wednesday, MarketBeat reports. They currently have a GBX 300 ($3.90) price target on the stock.

Advanced Medical Solutions Group Price Performance

Shares of Advanced Medical Solutions Group stock opened at GBX 203.50 ($2.65) on Wednesday. The stock’s 50-day simple moving average is GBX 211.34 and its 200-day simple moving average is GBX 212.81. Advanced Medical Solutions Group has a 52 week low of GBX 176.60 ($2.30) and a 52 week high of GBX 275.83 ($3.59). The company has a quick ratio of 4.58, a current ratio of 8.39 and a debt-to-equity ratio of 37.01. The company has a market capitalization of £439.41 million, a price-to-earnings ratio of 39.43, a PEG ratio of 5.00 and a beta of 0.74.

About Advanced Medical Solutions Group

(Get Free Report)

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.

Featured Stories

Receive News & Ratings for Advanced Medical Solutions Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Solutions Group and related companies with MarketBeat.com's FREE daily email newsletter.